From Gene Identifications to Therapeutic Targets for Asthma: Focus on Great Potentials of , and

Overview

Journal Chin Med J Pulm Crit Care Med

Date 2024 Aug 22

PMID 39171126

Authors

Youming Zhang

Affiliations

Soon will be listed here.

Abstract

Asthma is a chronic respiratory disease, and clinically, asthma exacerbations remain difficult to treat. The disease is caused by combinations of and interactions between genetic and environmental factors. Genomic and genetic approaches identified many novel genes to treat asthma and brought new insights into the disease. The products of the genes have functional roles in regulating physiological or pathophysiological processes in airway structural cells and immune system cells. Genetic factors also interact with environmental factors such as air pollutants, and bacterial and viral infections to trigger the disease. Thymic stromal lymphopoietin (), orosomucoid-like 3 (), and gasdermin B () are three genes identified by genetic studies to have a great potential as therapeutic targets of asthma. TSLP is an important driver of type 2 inflammation. ORMDL3 mediates cell stress, sphingolipid synthesis, and viral and bacterial infections. GSDMB regulates cell pyroptosis through its N and C terminals and can bind sulfatides to influence inflammatory response. Investigating inhibitors or modulators for these pathways would bring a new landscape for therapeutics of asthma in future.

Citing Articles

The function of serine/threonine-specific protein kinases in B cells.

Han Z, Benlagha K, Lee P, Park C, Filatov A, Byazrova M Front Immunol. 2024; 15:1459527.

PMID: 39445011 PMC: 11496051. DOI: 10.3389/fimmu.2024.1459527.

References

Corren J, Ziegler S . TSLP: from allergy to cancer. Nat Immunol. 2019; 20(12):1603-1609. DOI: 10.1038/s41590-019-0524-9. View

Ferreira M, Matheson M, Duffy D, Marks G, Hui J, Le Souef P . Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet. 2011; 378(9795):1006-14. PMC: 3517659. DOI: 10.1016/S0140-6736(11)60874-X. View

Maceyka M, Spiegel S . Sphingolipid metabolites in inflammatory disease. Nature. 2014; 510(7503):58-67. PMC: 4320971. DOI: 10.1038/nature13475. View

Chang Y, Kim H, Albacker L, Baumgarth N, McKenzie A, Smith D . Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol. 2011; 12(7):631-8. PMC: 3417123. DOI: 10.1038/ni.2045. View

Robinson D, Campbell D, Durham S, Pfeffer J, Barnes P, Chung K . Systematic assessment of difficult-to-treat asthma. Eur Respir J. 2003; 22(3):478-83. DOI: 10.1183/09031936.03.00017003. View

Sevin C, Aubourg P, Cartier N . Enzyme, cell and gene-based therapies for metachromatic leukodystrophy. J Inherit Metab Dis. 2007; 30(2):175-83. DOI: 10.1007/s10545-007-0540-z. View

Fahy J . Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc Am Thorac Soc. 2009; 6(3):256-9. DOI: 10.1513/pats.200808-087RM. View

Zhang Y, Willis-Owen S, Spiegel S, Lloyd C, Moffatt M, Cookson W . The ORMDL3 Asthma Gene Regulates ICAM1 and Has Multiple Effects on Cellular Inflammation. Am J Respir Crit Care Med. 2018; 199(4):478-488. PMC: 6376621. DOI: 10.1164/rccm.201803-0438OC. View

Broz P, Pelegrin P, Shao F . The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 2019; 20(3):143-157. DOI: 10.1038/s41577-019-0228-2. View

10.

Yan Q, Brehm J, Pino-Yanes M, Forno E, Lin J, Oh S . A meta-analysis of genome-wide association studies of asthma in Puerto Ricans. Eur Respir J. 2017; 49(5). PMC: 5527708. DOI: 10.1183/13993003.01505-2016. View

11.

Clarke E, Rahman N, Page N, Rolph M, Stewart G, Jones G . Functional characterization of the atopy-associated gene PHF11. J Allergy Clin Immunol. 2008; 121(5):1148-1154.e3. DOI: 10.1016/j.jaci.2008.02.028. View

12.

Allen M, Heinzmann A, Noguchi E, Abecasis G, Broxholme J, Ponting C . Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat Genet. 2003; 35(3):258-63. DOI: 10.1038/ng1256. View

13.

Gaffen S, Jain R, Garg A, Cua D . The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol. 2014; 14(9):585-600. PMC: 4281037. DOI: 10.1038/nri3707. View

14.

Gauvreau G, OByrne P, Boulet L, Wang Y, Cockcroft D, Bigler J . Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med. 2014; 370(22):2102-10. DOI: 10.1056/NEJMoa1402895. View

15.

Grishina Z, Pushkareva M, Pletjushkina O, Reiser G, Peters-Golden M, Sudina G . Sulfatides inhibit leukotriene synthesis in human polymorphonuclear granulocytes by a mechanism involving lipid rearrangement in intracellular membranes. Int J Biochem Cell Biol. 2007; 40(1):110-24. DOI: 10.1016/j.biocel.2007.07.001. View

16.

Ito K, Zhang Y . Fighting the Common Cold: ORMDL3 in the Crosshairs?. Am J Respir Cell Mol Biol. 2020; 62(6):676-677. PMC: 7258821. DOI: 10.1165/rcmb.2020-0052ED. View

17.

Brinkmann V, Cyster J, Hla T . FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant. 2004; 4(7):1019-25. DOI: 10.1111/j.1600-6143.2004.00476.x. View

18.

Dharmage S, Perret J, Custovic A . Epidemiology of Asthma in Children and Adults. Front Pediatr. 2019; 7:246. PMC: 6591438. DOI: 10.3389/fped.2019.00246. View

19.

Zhang Y, Poobalasingam T, Yates L, Walker S, Taylor M, Chessum L . Manipulation of dipeptidylpeptidase 10 in mouse and human and models indicates a protective role in asthma. Dis Model Mech. 2018; 11(1). PMC: 5818078. DOI: 10.1242/dmm.031369. View

20.

Zhang Y, Moffatt M, Cookson W . Genetic and genomic approaches to asthma: new insights for the origins. Curr Opin Pulm Med. 2011; 18(1):6-13. DOI: 10.1097/MCP.0b013e32834dc532. View